Supernus INDV
NASDAQ INDV
$36.25 +0.88 (+2.49%)
At close: Nov 2, 2026 · 4:00 PM EST

Supernus (INDV) Net Equity Issued and Repurchased (2022 - 2026)

Updated

Indivior Pharmaceuticals (INDV) recorded Net Equity Issued and Repurchased of -$177 million in Q2 2026.

Analysis

Supernus (INDV) Net Equity Issued and Repurchased (2022 - 2026) Analysis & Trends

For FY2025, Indivior Pharmaceuticals reported Net Equity Issued and Repurchased of -$9 million.

  • Across earlier years, Net Equity Issued and Repurchased came in at -$170 million in FY2024, -$30 million in FY2023, -$88 million in FY2022 and -$100 million in FY2021.
  • The Q2 2026 figure is the lowest quarterly Net Equity Issued and Repurchased in data going back to Q1 2024.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -177.00 Mn
Mar 31, 2026 -125.00 Mn
Sep 30, 2025 1.00 Mn
Mar 31, 2025 -10.00 Mn
Dec 31, 2024 -50.00 Mn
Sep 30, 2024 -51.00 Mn
Jun 30, 2024 -35.00 Mn
Mar 31, 2024 -34.00 Mn
Dec 31, 2023 -45.00 Mn
Sep 30, 2023 2.00 Mn
Mar 31, 2023 2.00 Mn
Dec 31, 2022 -156.00 Mn
Sep 30, 2022 37.00 Mn
API Access

Supernus Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=INDV&period=max&api_key=YOUR_API_KEY